February 26, 2015
Singapore General Hospital
Clinical Applications of Stem Cells in Singapore
Feb 26th & 27th 2015
Taking Place at Singapore General Hospital
The Singapore Bioimaging Consortium and Select Biosciences South East Asia present the Annual Clinical Applications of Stem Cells. Led by Dr. Larry Stanton, Senior Group Leader from the Genome Institute of Singapore as the Convention Chairman.
The conference plans to bring together research workers and clinicians focusing on translating fundamental discoveries in the stem cells field into uses for regenerative medicine and advanced cellular therapy for diseases such COPD, Kidney Failure,Diabetes and Liver Disease. The conference also seeks to be looking particularly into the way the international regulatory agencies see the translational attempts.
The assembly will run over two full days, with demonstrations from clinicians, regulatory bodies, academia and business, leading into panel discussions each day to cover the points raised during the earlier sessions. Attending this stem cell seminar in Singapore will give you a comprehensive breakdown of the present research, clinical practices and regulatory conditions in this fast developing field in Asia.
- Lawrence Stanton, Senior Group Leader/Associate Manager, Stem Cell and Regenerative Biology, Genome Institute of Singapore
- Shigeki Sugii, Group Leader/Assistant Professor, Singapore Bioimaging Consortium/Duke NUS Graduate Medical School
- Teck Sin Lim, Creator, Adigenics
Selected Papers from the Clinical Applications of Stem Cells
- The Journal of Clinical Medicine is an international, peer reviewed open access journal.
- As a journal associate for the Clinical Uses of Stem Cells, JCM will generate a particular issue entitled “Selected Papers from the Clinical Applications of Stem Cells” and release the views and research results presented in the seminar.
The Guest Editor for the particular issue will likely be the Convention Chairman, Dr. Larry Stanton, Senior Group Leader/Associate Manager, Stem Cell and Regenerative Biology, Genome Institute of Singapore. The journal provides a platform for discussing improvements in health care/clinical practices, for the study of direct observation of patients, and for general medical research.
There’s absolutely no limit to publication length: the objective would be to motivate scientists to publish their experimental and theoretical results in as much detail as possible. JCM is an associate of the Committee on Publication Ethics (COPE).
To learn more about this conference or to add your international meeting or symposium to our calendar please contact us today.